MedPath

se of a mobile phone application to improve drug compliance in children with epilepsy.

Phase 2
Conditions
Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
Registration Number
CTRI/2023/10/058342
Lead Sponsor
All India Institute of Medical Sciences, Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children with Drug Resistant Epilepsy

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The feasibility & efficacy of a mobile phone application in improving medication adherence in children with drug-resistant epilepsy as assessed by the Morisky Green & Levine Adherence Scale (MGLS) and pill count methodTimepoint: 0 month <br/ ><br>3 months <br/ ><br>6 months
Secondary Outcome Measures
NameTimeMethod
The utility & efficacy of a mobile phone application in reduction of seizures burden in children with drug resistant epilepsy as assessed by the Early Childhood Epilepsy Severity ScoreTimepoint: 0 month <br/ ><br>3 months <br/ ><br>6 months
© Copyright 2025. All Rights Reserved by MedPath